Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
186M
-
Number of holders
-
163
-
Total 13F shares, excl. options
-
112M
-
Shares change
-
+279K
-
Total reported value, excl. options
-
$3.1B
-
Value change
-
+$8.76M
-
Put/Call ratio
-
0.87
-
Number of buys
-
99
-
Number of sells
-
-53
-
Price
-
$27.68
Significant Holders of Revolution Medicines, Inc. - Common Stock (RVMD) as of Q3 2023
199 filings reported holding RVMD - Revolution Medicines, Inc. - Common Stock as of Q3 2023.
Revolution Medicines, Inc. - Common Stock (RVMD) has 163 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 112M shares
of 186M outstanding shares and own 60.14% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (10.6M shares), VANGUARD GROUP INC (9.64M shares), BlackRock Inc. (8.87M shares), EcoR1 Capital, LLC (5.58M shares), PRICE T ROWE ASSOCIATES INC /MD/ (5.09M shares), Nextech Invest Ltd. (4.84M shares), Bellevue Group AG (4.72M shares), Boxer Capital, LLC (4.68M shares), JPMORGAN CHASE & CO (4.28M shares), and BVF INC/IL (3.98M shares).
This table shows the top 163 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.